Document Detail

Poly(glutamic acid) for biomedical applications.
MedLine Citation:
PMID:  11797908     Owner:  NLM     Status:  MEDLINE    
Paclitaxel is a widely used anti-cancer agent. Conjugates of paclitaxel with poly(glutamic acid) have shown great promise in preclinical trials, and clinical trials are now underway. Preclinical data suggest that more paclitaxel is preferentially delivered to tumor sites vs. nonconjugated paclitaxel. When poly(glutamic acid) is conjugated to other families of cancer drugs, similar improvements in effectiveness and reduced toxicity are observed. Optimization of poly(glutamic acid) for use in drug delivery applications is a key step in making this technology viable.
A Richard; A Margaritis
Related Documents :
1182188 - The effect of ageing on in vitro fidelity of translation in mouse liver.
18941618 - Synthesis of thienyl analogues of pcbm and investigation of morphology of mixtures in p...
17113698 - The role of acrylophosphonic acid monomers in the formation of hybrid layers based on s...
1704198 - Single-stranded rna molecular weight and shape determination by differential pressure c...
9512978 - Effects of omega-3 fatty acids on renal function and electrolyte excretion in aged pers...
6407328 - Horse eosinophil degranulation induced by the ionophore a23187. ultrastructure and role...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Critical reviews in biotechnology     Volume:  21     ISSN:  0738-8551     ISO Abbreviation:  Crit. Rev. Biotechnol.     Publication Date:  2001  
Date Detail:
Created Date:  2002-01-18     Completed Date:  2002-06-25     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8505177     Medline TA:  Crit Rev Biotechnol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  219-32     Citation Subset:  IM    
Department of Chemical and Biochemical Engineering, The University of Western Ontario, London, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Delivery Systems*
Peptide Hydrolases / metabolism
Polyglutamic Acid / administration & dosage*,  biosynthesis,  metabolism
Reg. No./Substance:
25513-46-6/Polyglutamic Acid; EC 3.4.-/Peptide Hydrolases; EC 3.4.-/polyglutamyl gamma-hydrolase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Historical site assessments--they're not just for decommissioning anymore.
Next Document:  Hydrodynamic and mass transfer characteristics of three-phase gaslift bioreactor systems.